Wells Fargo & Company Nex Immune, Inc. Transaction History

Wells Fargo & Company

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.2 - $0.3 $2 - $3	-13 Reduced 9.35%	126 $0
Q2 2023 Aug 15, 2023	BUY	$0.26 - $0.47 $1 - $2	6 Added 4.51%	139 $0
Q1 2023 May 12, 2023	BUY	$0.3 - $0.6 $3 - $6	11 Added 9.02%	133 $0
Q4 2022 Feb 13, 2023	BUY	$0.21 - $18.5 $2 - $185	10 Added 8.93%	122 $0
Q3 2022 Nov 14, 2022	BUY	$0.6 - $17.5 $39 - $1,155	66 Added 143.48%	112 $0
Q2 2022 Aug 12, 2022	SELL	$1.61 - $4.68 $12,202 - $35,469	-7,579 Reduced 99.4%	46 $0
Q1 2022 May 16, 2022	SELL	$1.79 - $4.65 $4,267 - $11,085	-2,384 Reduced 23.82%	7,625 $32,000
Q4 2021 Feb 14, 2022	BUY	$4.11 - $15.13 $40,927 - $150,664	9,958 Added 19525.49%	10,009 $46,000
Q3 2021 Nov 15, 2021	SELL	$10.32 - $16.9 $75,253 - $123,234	-7,292 Reduced 99.31%	51 $1,000
Q2 2021 Aug 16, 2021	BUY	$14.98 - $23.89 $79,978 - $127,548	5,339 Added 266.42%	7,343 $120,000
Q1 2021 May 13, 2021	BUY	$17.95 - $25.91 $35,971 - $51,923	2,004 New	2,004 $38,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $7.25M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.